Compare SSD & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SSD | ALKS |
|---|---|---|
| Founded | 1956 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.7B |
| IPO Year | 1996 | 2012 |
| Metric | SSD | ALKS |
|---|---|---|
| Price | $195.25 | $49.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 14 |
| Target Price | ★ $214.75 | $43.43 |
| AVG Volume (30 Days) | 241.3K | ★ 1.7M |
| Earning Date | 04-27-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.61% | N/A |
| EPS Growth | ★ 8.42 | N/A |
| EPS | ★ 5.22 | N/A |
| Revenue | ★ $2,332,808,000.00 | $1,475,899,000.00 |
| Revenue This Year | $3.82 | $24.26 |
| Revenue Next Year | $5.57 | $4.47 |
| P/E Ratio | $37.32 | ★ N/A |
| Revenue Growth | ★ 4.51 | N/A |
| 52 Week Low | $156.32 | $25.17 |
| 52 Week High | $213.49 | $55.67 |
| Indicator | SSD | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 52.17 | 47.74 |
| Support Level | $183.25 | $47.66 |
| Resistance Level | $195.67 | $50.85 |
| Average True Range (ATR) | 5.54 | 1.96 |
| MACD | 0.58 | -0.25 |
| Stochastic Oscillator | 45.75 | 29.75 |
Simpson Manufacturing Co Inc designs, manufactures, and markets systems and products to make buildings and structures safe and secure. It produces wood construction products, including connectors, truss plates, fastening systems, fasteners, and shearwalls, as well as concrete construction products such as adhesives, specialty chemicals, mechanical anchors, powder actuated tools, and fiber reinforcing materials. The company serves residential, industrial, commercial, and infrastructure construction, remodeling, and do-it-yourself markets, operating exclusively in the building products industry. It has three regional segments: North America, Europe, and Asia/Pacific. The majority of its revenue comes from wood products.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.